Location History:
- Brussels, BE (2003 - 2016)
- Rixensart, BE (2022)
Company Filing History:
2 out of 1,744 
1 out of 870 
1 out of 525 
Years Active: 2003-2022
Title: Innovations and Contributions of Inventor Sandra Morel
Introduction
Sandra Morel is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of immunology, particularly in the prevention and treatment of autoimmune diseases and cancer. With a total of 3 patents, her work has the potential to impact many lives.
Latest Patents
One of her latest patents focuses on the use of adjuvants for the prevention and/or treatment of autoimmune diseases. This invention provides an adjuvant that can be utilized in combating autoimmune conditions. Another notable patent involves an immunogenic composition that comprises a recombinant protein and a peptide corresponding to a tumor antigen, aimed at cancer treatment. This therapeutic composition is particularly relevant for melanoma, incorporating specific epitopes from the HLA*0201 epitope, including Tyr or GnT-V.
Career Highlights
Sandra Morel has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and the Pasteur Institute (Institut Pasteur). Her research and innovations have garnered attention in the scientific community.
Collaborations
Throughout her career, Sandra has collaborated with notable colleagues, including Gilles Dadaglio and Claude Leclerc. These partnerships have further enriched her research endeavors and contributions to the field.
Conclusion
Sandra Morel's innovative work in immunology showcases her dedication to advancing medical science. Her patents and collaborations reflect her commitment to improving health outcomes for individuals affected by autoimmune diseases and cancer.